Benzodiazepines

What are benzodiazpines? 

Benzodiazepines may be implemented as an adjunct to antipsychotic medication in order to treat acute symptoms of psychosis such as agitation, aggression, irritability, or anxiety. They may also be used to treat side effects of antipsychotic medications such as movement disorders including tardive dyskinesia, however they are associated with their own side effects and are associated with well-established patterns of tolerance and dependence, so they are prescribed with caution.

What is the evidence on benzodiazepines?

Moderate to low quality evidence suggests no additional benefit of adjunctive benzodiazepine for reducing agitation or excitation in the short term (up to 30 minutes); however benzodiazepines may be associated with a faster time to sedation than antipsychotics alone, better global improvements (up to 60 minutes) and lower risk of movement disorders. No significant difference was found between adjunct benzodiazepines and antipsychotics alone for other outcomes including the need for additional medication, study attrition, mental state, aggression, and hospitalisation.

March 2019

Last updated at: 10:27 pm, 20th March 2019
To view documentation related to this topic download the files below
Fact Sheet Technical Commentary

NeuRA Libraries

Title Colour Legend:
Green - Topic summary is available.
Orange - Topic summary is being compiled.
Red - Topic summary has no current systematic review available.